Progesterone Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

The Progesterone Market was valued at USD 203.92 Million in 2024 and is projected to reach USD 242.58 Million by 2030, rising at a CAGR of 1.89%. Progesterone is a vital hormone widely used across hormone replacement therapies (HRT), contraceptives, fertility treatments, and veterinary applications. Its critical role in regulating ovulation and sustaining pregnancy makes it essential in both human and animal health sectors. Increasing infertility rates and expanding access to assisted reproductive technologies (ART), such as IVF, are fueling demand for progesterone-based formulations. Rising global awareness of reproductive and menopausal health is also driving market growth, particularly in emerging economies. However, the market continues to face challenges from regulatory complexities, potential adverse effects of long-term hormone therapy, and fluctuations in raw material supply and production costs.

Key Market Drivers

Growth in Pharmaceutical Industry

The expanding focus on women’s health, particularly related to menopause, fertility, and hormonal disorders, is a major factor driving demand for progesterone. As more women seek treatment for conditions like perimenopause, endometriosis, and PCOS, progesterone is increasingly used in HRT and therapeutic solutions. Rising age-related hormonal concerns in developed markets with greater healthcare access further support this trend.

In addition, the global burden of infertility is intensifying demand for ART procedures, in which progesterone is commonly administered to support embryo implantation and early pregnancy. With approximately 1 in 6 adults experiencing infertility globally, the need for effective, affordable, and accessible fertility care has grown. Progesterone’s integral role in IVF and similar procedures is contributing to its rising use in fertility medications across both developed and developing markets, where awareness and accessibility of such treatments continue to expand.

Key Market Challenges

Safety Concerns and Side Effects

One of the major challenges in the progesterone market is the range of safety concerns and adverse effects associated with its long-term or high-dosage use, especially in HRT and fertility therapies. Common side effects include fatigue, bloating, mood changes, and headaches, while more severe risks such as thromboembolic events, cardiovascular complications, and increased cancer risk - particularly when used alongside estrogen - have raised caution.

In ART procedures, progesterone is essential for luteal phase support, but hormone supplementation may result in conditions like ovarian hyperstimulation syndrome (OHSS) and weight gain, which could deter treatment adherence. These health concerns affect prescription rates and patient trust, posing limitations to widespread adoption despite progesterone’s clinical importance in reproductive care.

Key Market Trends

Rise in Menopause Awareness

Growing global awareness about menopause and related hormonal imbalances is shaping demand for effective hormone replacement therapies that include progesterone. With rising life expectancy and an expanding population of women aged 50 and above, the need for symptom management and quality-of-life improvements is increasing. Progesterone, when used with estrogen in HRT, mitigates risks such as endometrial cancer, making it a critical component of balanced therapy.

The trend toward bioidentical hormones, which closely replicate the body’s natural hormone structure, is gaining traction. Bioidentical progesterone is increasingly preferred over synthetic alternatives due to its perceived safety and better compatibility with the body, making it a popular choice among women seeking natural options for menopause symptom management. This shift is fueling innovation and driving growth in the global progesterone market.

Key Players Profiled in this Progesterone Market Report

• NAARI PHARMA Pvt. Ltd
• La Chandra Pharmalab
• BGP Laboratories Private Limited
• V M Lifescience
• Mankind Pharma Ltd
• Bhugan Lifescience Pvt Ltd
• Abcures Biosciences LLP
• Symbiotec Pharmalab
• Granth Pharma Pvt Ltd
• Emote Lifesciences LLP

Report Scope

In this report, the Global Progesterone Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Progesterone Market, by Sales Channel:

• Direct
• Indirect

Progesterone Market, by End Use:

• Hormone Replacement Therapy
• Infertility Treatment
• Menstrual Disorders
• Premenstrual Syndrome (PMS)
• Others

Progesterone Market, by Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Progesterone Market.

Available Customizations

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.